A detailed history of Cresset Asset Management, LLC transactions in Geron Corp stock. As of the latest transaction made, Cresset Asset Management, LLC holds 169,200 shares of GERN stock, worth $482,220. This represents 0.0% of its overall portfolio holdings.

Number of Shares
169,200
Previous 166,502 1.62%
Holding current value
$482,220
Previous $705,000 8.94%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.17 - $4.99 $11,250 - $13,463
2,698 Added 1.62%
169,200 $768,000
Q2 2024

Aug 14, 2024

BUY
$3.1 - $5.09 $7,632 - $12,531
2,462 Added 1.5%
166,502 $705,000
Q1 2024

May 15, 2024

BUY
$1.75 - $3.44 $5,960 - $11,716
3,406 Added 2.12%
164,040 $541,000
Q4 2023

Feb 14, 2024

BUY
$1.74 - $2.31 $5,898 - $7,830
3,390 Added 2.16%
160,634 $338,000
Q3 2023

Nov 14, 2023

BUY
$2.11 - $3.28 $4,724 - $7,343
2,239 Added 1.44%
157,244 $333,000
Q2 2023

Aug 14, 2023

BUY
$1.97 - $3.69 $305,359 - $571,968
155,005 New
155,005 $497,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.08B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Cresset Asset Management, LLC Portfolio

Follow Cresset Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cresset Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cresset Asset Management, LLC with notifications on news.